TNF and cancer: Exosomal mRNAs encoding cytokines (e.g., IL-1β, TNF-α) or enzymes (e.g., COX2) can be delivered to recipient cells, enhancing the inflammatory response, and can be translated into recipient immune cells, promoting the production of inflammatory mediators and sustaining chronic inflammation, which is a cancer-promoting factor [14].